Our Location
‍
CRS operates a dedicated Phase I clinical unit in the European Union, configured to support controlled inpatient studies in healthy volunteers. The unit is designed for early-phase clinical research conducted in sequential cohorts, with operational layouts appropriate for safety monitoring and protocol-driven study conduct.
Our Phase I infrastructure is organized across two coordinated units, allowing flexible study planning while maintaining a controlled clinical environment. The facilities support inpatient study conduct, subject observation, dosing activities, and on-site clinical operations aligned with early-phase requirements.All study activities are supported by experienced clinical staff and established operational procedures appropriate for early-phase clinical research within the EU regulatory context.

Our staff
‍
and collaborators are professionals with many years of experience. Our two clinical trial facilities include adaptive clinical pharmacology units for Phase I and II studies in healthy normal volunteers (HNV) and patient populations for small and large molecules. For long or short stays, our units have a team of experts to conduct trials in a range of therapeutic areas. With dedicated in-house pharmacy, we are the single-source solution to your small and large moleculeearly-phase clinical trial needs.
‍
Recruitment
‍
‍Our advanced level of clinical expertise enables us to successfully recruit and conduct clinical trials involving a broad range of healthy normal, special, and patient populations. Leveraging a combination of our existing database and proactive participant outreach strategies, we can help you get ahead in a wide range of study types, methods of administration, and therapeutic areas.
‍
Our Capability
‍
72+ bed dedicated early-phase unit.
Experienced investigators and continuous medical oversightIn-house
Pharmacy and IMP handling
Intensive PK sampling and processing
Hospital access and emergency coverage
EU & EMA-aligned regulatory compliance
‍